股票名称:华东医药 | 股票代码:000963 | |
研报类型:(PDF) | 研报栏目:定期财报 | |
研报大小:787K | 分享时间:2019-11-08 20:46:02 |
2019ThirdQuarterlyReportofHuadongMedicineCo.,Ltd.1HuadongMedicineCo.,Ltd.2019ThirdQuarterlyReportOctober20192019ThirdQuarterlyReportofHuadongMedicineCo.,Ltd.2SectionIImportantNotesTheBoardofDirectors,BoardofSupervisors,directors,supervisorsandseniormanagementofHuadongMedicineCo.,Ltd.(the“Company”)herebyguaranteethattheinformationpresentedinthisreportisauthentic,accurateandcompleteandfreeofanyfalserecords,misleadingstatementsormaterialomissions,andwillundertakeindividualandjointlegalliabilities.Alldirectorshaveattendedtheboardmeetingtoreviewthisquarterlyreport.LyuLiang,theCompany’slegalrepresentativeandtheofficerinchargeofaccounting,andMaHonglan,headofaccountingdepartment(accountingsupervisor)herebydeclareandwarrantthatthefinancialstatementsinthisreportareauthentic,accurateandcomplete.Accordingto“StockListingRulesoftheShenzhenStockExchange(2018Revision)”,iflistedcompanieshavebothChineseandotherlanguageversionsofpublicnotice,theyshouldensurethecontentofbothversionsarethesame.Inthecaseofdiscrepancy,theoriginalversioninChineseshallprevail.2019ThirdQuarterlyReportofHuadongMedicineCo.,Ltd.3SectionIICompanyProfileI.KeyaccountingdataandfinancialindicatorsWhethertheCompanyneedstoperformaretroactiveadjustmentorrestatementofthepreviousaccountingdata√Yes□NoReasonsforretroactiveadjustmentorrestatementOtherreasonAtSeptember30,2019AtDecember31,2018ChangebetweenDecember31,2018andSeptember30,2019(%)BeforeadjustmentAfteradjustmentAfteradjustmentTotalassets(yuan)22,510,034,334.4819,217,357,282.3319,217,357,282.3317.13%NetassetsattributabletoshareholdersoftheCompany(yuan)11,661,608,297.709,938,148,996.539,938,148,996.5317.34%2019Q3YoYChangebetween2018Q3and2019Q3(%)2019Q1-Q3YoYChangebetween2018Q1-Q3and2019Q1-Q3(%)Operatingrevenue(yuan)9,379,217,601.8919.03%27,627,885,218.8719.06%NetprofitsattributabletoshareholdersoftheCompany(yuan)616,830,635.7719.61%2,213,114,054.0822.33%NetprofitsattributabletoshareholdersoftheCompanyafterdeductingnon-recurringprofitorloss(yuan)605,703,004.5217.68%2,079,980,188.5516.59%Netcashflowsfromoperatingactivities(yuan)--909,038,245.94-35.59%Basicearningspershare(yuanpershare)0.352519.61%1.264822.33%Dilutedearningspershare(yuanpershare)0.352519.61%1.264822.33%WeightedaverageReturnonEquity(ROE)5.44%-0.14%20.14%0.18%Note:AstheCompanyincreasedsharecapitalbyconvertingcapitalreserveinJune2019,earningspershareofprecedingperiodwasadjustedbasedontheincreasedcapitalunderrelevantaccountingstandards……
不良信息举报电话:400-806-1866 举报邮箱:hbzixun@126.com